Blake Corum is poised to become a bigger part of the Rams offense in 2026, and he's a strong breakout candidate.

RLI Corp. maintains more than 50 years of gradual dividend increases, supplemented by regular special dividends. Read more on ...

LiveWire Group is reiterated at Sell with a $1.12/share PT, reflecting solvency and profitability concerns despite recent ...

Hypertension affects more than 1.4 billion people worldwide and many patients remain uncontrolled despite multiple therapies ...

The following is the transcript of the interview with U.S. Trade Representative Jamieson Greer that aired on "Face the Nation ...

ESPN projects Tennessee Titans rookies Carnell Tate and Keldric Faulk to be among the NFL's top performers in 2026.

AstraZeneca’s BAXFENDY™ (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with other antihypertensive ...

The NFL changes faster than any other league. A team can miss the playoffs one year and become a championship threat the next ...

The Boston Celtics have been named as a potential trade destination for the $37.6 Million Big Man, who could plug a ...

They signed JJ Bleday to a one-year, $1.4 million contract this offseason after he was non-tendered by the A's, and most ...

The central midfielder left the Hanseatic city as a celebrated promotion hero, but in Brugge he has so far failed to find ...

US FDA approves AstraZeneca’s Baxfendy, an aldosterone synthase inhibitor to treat adults with hypertension: Cambridge, UK Wednesday, May 20, 2026, 10:00 Hrs [IST] AstraZenecas ...